A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/215 (2006.01) A61K 9/20 (2006.01) A61K 31/13 (2006.01) A61K 31/135 (2006.01) A61K 31/195 (2006.01) A61K 31/198 (2006.01) A61K 31/216 (2006.01) A61K 31/275 (2006.01) A61K 47/30 (2006.01) A61K 47/38 (2006.01) A61P 25/16 (2006.01)
Patent
CA 2227208
The present invention provides a pharmaceutical composition containg a therapeutically effective amount of L-DOPA ethyl ester and a carrier which comprises from 5.5 to 98.5 % hydroxypropylmethyl cellulose, from 0.25 to 4.5 % hydroxypropyl cellulose, and from 1 to 90 % of a carboxyvinyl polymer.
Cette invention porte sur une composition pharmaceutique contenant une quantité efficace du point de vue thérapeutique d'ester éthylique de lévodopa ainsi qu'un véhicule comprenant de 5,5 à 98,5 % d'hydroxypropylméthylcellulose, de 0,25 à 4,5 % d'hydroxypropylcellulose et de 1 à 90 % d'un carboxypolyméthylène.
Atlas Dafna
Cohen Sasson
Levy Ruth
Melamed Eldad
Shterman Nava
Gowling Lafleur Henderson Llp
Teva Pharmaceutical Industries Ltd.
Yissum Research Development Company Of The Hebrew University Of
LandOfFree
Pharmaceutical composition of l-dopa ethyl ester does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of l-dopa ethyl ester, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of l-dopa ethyl ester will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486674